ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 101.20
+0.20 (0.20%)
Sep 9, 2026, 5:35 PM CET
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €8.8 billion as of September 9, 2026. Its market cap has increased by 54.70% in one year.
Market Cap
8.80B
Enterprise Value
8.35B
Revenue
4.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
€101.20
ChartMarket Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 8.80B, an increase of 4,255.39%. That is a compound annual growth rate of 40.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 8.80B | -6.06% |
| Dec 31, 2025 | 9.37B | 2,088.64% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.65B |
| Inventiva | 951.03M |
| MedinCell | 811.60M |
| DBV Technologies | 689.48M |
| Genfit | 655.32M |
| Valneva SE | 563.82M |
| Valerio Therapeutics Société anonyme | 355.61M |
| Transgene | 242.11M |